Carlsmed (CARL) Income Statement: Revenue & Earnings

Carlsmed Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Carlsmed, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023
Period Ending	Dec 2024	Dec 2023
Revenue & Gross Profit
Revenue	27.17	13.78
Cost of Revenue	7.12	3.88
Gross Profit	20.05	9.90
Operating Expenses
Research & Development	14.30	7.40
Selling, General & Administrative	29.87	21.10
Operating Expenses	44.17	28.49
Operating Income	-24.12	-18.59
Other Income/Expense
Interest Income	1.33	0.33
Interest Expense	1.32	0.64
Other Income/Expense	-0.14	0.00
Income
Income Before Tax	-24.26	-18.90
Income Tax Expense	0.00	0.00
Net Income	-24.26	-18.90
Net Income - Continuous Operations	-24.26	-18.90
Net Income - Discontinued Operations	0.00	0.00
EBITDA	-22.79	-18.12
EBIT	-22.94	-18.26
Depreciation & Amortization	0.15	0.14
Earnings Per Share
Basic EPS	-1.00	-4.00
Diluted EPS	-1.00	-4.00
Basic Shares Outstanding	16.56	4.45
Diluted Shares Outstanding	16.56	4.45